Becton, Dickinson and Company
$17.8M 12,620 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Taiho Oncology, Inc.
Taiho Oncology, Inc. reported $17,611,301.25 across General Payments, Research, and Ownership to 5,970 physicians and teaching hospitals across 6,767 transactions.
- $17.6M Top 10% payer
- All-tracks total
- 6,767 Top quartile volume
- Transactions
- 5,970 Top quartile reach
- Recipients
- −$811.9K
- General Payments vs PY2023
Taiho Oncology, Inc. reported $17,611,301.25 across all CMS Open Payments tracks (General + Research + Ownership) to 5,970 physicians and teaching hospitals in Program Year 2024 - ranking #104 of 1,925 reporting manufacturers (0.1% of the all-tracks industry total); General Payments alone were $844,416.49, averaging $2.9K per recipient.
How Taiho Oncology, Inc.'s $17.6M all-tracks total breaks down
Taiho Oncology, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
C
76/100
Total payments
A
100/100
Transaction volume
D
59/100
Physician reach
D
55/100
Payment type diversity
A
90/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer taiho-oncology-inc Taiho Oncology, Inc.
$17.6M · #104/1,925 · 0.1% industry · PY2024
- TOT $17.6M
- RANK #104
- SHARE 0.1%
- TXN 6,767
- RCP 5,970
- CAT 7
- GEN $844.4K
- ΔGEN −$811.9K
- TOP1 10.8%
- PY 2024
Volume peers
Nearest volume peer: Becton, Dickinson and Company ($17.8M)
Taiho Oncology, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Taiho Oncology, Inc.'s CMS-reported General Payments decreased by $811.9K (−49.0%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: TAIHO ONCOLOGY, INC.PY2023: TAIHO ONCOLOGY, INC.PY2024: TAIHO ONCOLOGY, INC.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $1,656,279.19
- PY2024
- $844,416.49
What the Data Shows for Taiho Oncology, Inc.
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Taiho Oncology, Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
The 7-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Compensation for Services Other Than Consulting" at $340.3K, accounting for 40.3% of this company's General Payments and 97 transactions.
General Payment Breakdown by Type
Taiho Oncology, Inc. made 7 types of general payments. "Compensation for Services Other Than Consulting" is the largest category at $340.3K, 40.3% of General Payments.
Taiho Oncology, Inc. reports 7 general-payment categories - the top three are Compensation for Services Other Than Consulting (40.3%), Consulting Fee (25.3%), and Food and Beverage (14.7%). The remaining 4 categories make up 19.7% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Taiho Oncology, Inc. divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Compensation for Services Other Than Consulting | $340.3K | 97 | 40.3% |
| Consulting Fee | $213.5K | 106 | 25.3% |
| Food and Beverage | $124.3K | 5,407 | 14.7% |
| Space Rental or Facility Fees | $94.0K | 29 | 11.1% |
| Travel and Lodging | $57.4K | 288 | 6.8% |
| Education | $10.4K | 9 | 1.2% |
| Compensation for Faculty or Speaker (Medical Education) | $4.5K | 34 | 0.5% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $197,775.42 (23.4%) of $844,416.49 in this company's General Payments records across 3,227 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Taiho Oncology, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Michael Morse
$91,456.88 across 84 reported transactions
- 2
Bart Scott
$31,667.39 across 20 reported transactions
- 3
Ben George
$29,469.83 across 19 reported transactions
- 4
Mayo Clinic Hospital
$22,595.00 across 5 reported transactions
- 5
Putao Cen
$22,586.32 across 22 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Taiho Oncology, Inc. ranks #104 of 1,925 by total payments (top 5% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,541 of 1,838 by HHI (bottom 16% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Azurity Pharmaceuticals, Inc. : $281.2K total payments, HHI 218
- Mirum Pharmaceuticals, Inc. : $1.2M total payments, HHI 218
- Biofrontera Inc. : $252.6K total payments, HHI 217
- Steelhead Surgical Inc : $51.2K total payments, HHI 217
- Artivion, Inc. : $449.9K total payments, HHI 216
- Kettenbach LP : $2.6K total payments, HHI 216
- Taiho Oncology, Inc. (this company) : $844.4K total payments, HHI 215
- Accord Healthcare, Inc. : $181.0K total payments, HHI 215
- Cgg Medical Inc : $149.7K total payments, HHI 214
- QOL Medical, LLC : $693.7K total payments, HHI 214
- Mentor Worldwide LLC : $1.0M total payments, HHI 213
- Avation Medical, Inc. : $4.0K total payments, HHI 213
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Taiho Oncology, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Taiho Oncology, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Taiho Oncology, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Ultragenyx Pharmaceutical Inc.
$17.8M 2,488 recipients
Compare payment profiles
CSL Plasma Inc.
$17.9M 12,905 recipients
Compare payment profiles
Sarepta Therapeutics, Inc.
$17.2M 1,307 recipients
Compare payment profiles
Spinecraft, LLC
$18.2M 27 recipients
Compare payment profiles
Align Technology, Inc.
$17.0M 55,540 recipients
Compare payment profiles
Put this to use
Taiho Oncology, Inc. ranks #104 of 1,925 by all-tracks total payments, led by "Compensation for Services Other Than Consulting".
- See where Taiho Oncology, Inc. sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Compensation for Services Other Than Consulting" spend across every manufacturer, not just Taiho Oncology, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.